MEDPAGE Today글 소개

FDA OKs Remdesivir Emergency Use for Severe COVID-19

— From the first case diagnosed to a therapeutic in just weeks

by Molly Walker, Associate Editor, MedPage Today May 1, 2020

share to facebook

The FDA approved an emergency use authorization (EUA) for remdesivir, an investigational antiviral agent,  to treat patients hospitalized with severe COVID-19, the agency said Friday.

Authorization was granted on the basis of two clinical trials, including results from a randomized trial of remdesivir released by the National Institute of Allergy and Infectious Diseases in a press release this week. Interim analyses of the trial showed the drug met its primary endpoint, a 31% significantly faster time to recovery over controls.